News

Hims & Hers Health, Inc. (HIMS) Alleged“Deceptive” Marketing Of Wegovy® Triggers Securities Class Actions HIMS Investors With Losses Encouraged To Contact Hagens Berman
National shareholders rights firm Hagens Berman continues to investigate the legal claims and urges Hims & Hers investors who suffered substantial losses to submit your losses now . The firm also ...
Weight-Loss Drugs Telehealth Platform Hims & Hers Hit With New Lawsuit
On April 29, 2025, Hims & Hers and Novo Nordisk unveiled a landmark collaboration to bring Wegovy—Novo's blockbuster semaglutide-based weight‑loss injection—to Hims & Hers' digital storefront. The ...